Kexing Biopharm Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kexing Biopharm Co Ltd

Watchlist Manager

Watchlist

Price: 22.93 CNY -1.46% Market Closed

Market Cap: ¥4.6B

	Kexing Biopharm Co Ltd SSE:688136	CN
	Molina Healthcare Inc NYSE:MOH	US
	Bollore SE F:BOP	FR
	Pro-Dex Inc NASDAQ:PDEX	US
P	PepsiCo Inc XHAM:PEP	US
	Citizen Watch Co Ltd TSE:7762	JP
	Aeon Co Ltd F:JUS	JP
S	Stora Enso Oyj XMUN:ENUA	FI
N	Nintendo Co Ltd F:NTO	JP
W	Waters Corp LSE:0LTI	US

Profitability Summary

Kexing Biopharm Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

72% > 59%

Negative Operating Margin

-2%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-15% > -2%

Healthy Net Margin

15%

Low 3Y Average Net Margin

Net Margin is Increasing

-11% > 15%

Negative Free Cash Flow Margin

-1%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

ROIC is Increasing

-7% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.